SCHEMBL5700

SCHEMBL5700

OCCc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.80
EPHX2 P34913 1/20 0.80
CYP4F2 P78329 1/20 0.69
CYP4A11 Q02928 1/20 0.69
FFAR1 O14842 3/20 0.67
FFAR4 Q5NUL3 1/20 0.67
LMNA P02545 1/20 0.66
CYP1A2 P05177 1/20 0.66
PTGS1 P23219 1/20 0.66
SLC6A2 P23975 1/20 0.66
CYP2C19 P33261 1/20 0.66
PTGS2 P35354 1/20 0.66
SLC6A3 Q01959 1/20 0.66
HIF1A Q16665 1/20 0.66
HDAC6 Q9UBN7 1/20 0.66
TDP1 Q9NUW8 1/20 0.61
BCHE P06276 3/20 0.60
MAOB P27338 2/20 0.59
GAA P10253 1/20 0.58
MAPT P10636 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL5852437 0.95 LTA4H (0.73) LTA4HEPHX2CYP4F2CYP4A11FFAR1
SCHEMBL6029 0.94 CYP4F2 (0.71) LTA4HEPHX2CYP4F2CYP4A11FFAR1
SCHEMBL1563277 0.89 LTA4H (1.00) LTA4HEPHX2CYP4F2CYP4A11FFAR1
SCHEMBL18625341 0.87 CYP4F2 (0.63) LTA4HEPHX2CYP4F2CYP4A11FFAR1
SCHEMBL17609087 0.87 LTA4H (0.63) LTA4HEPHX2CYP4F2CYP4A11FFAR1
SCHEMBL11687518 0.87 LTA4H (0.97) LTA4HEPHX2FFAR1FFAR4LMNA
SCHEMBL5760428 0.87 LTA4H (0.90) LTA4HEPHX2CYP4F2CYP4A11FFAR1
Azelaic Acid SCHEMBL21879788 0.86 FFAR1 (0.73) LTA4HEPHX2FFAR1FFAR4MAPT
Pimelic Acid SCHEMBL21879736 0.86 FFAR1 (0.73) LTA4HEPHX2FFAR1FFAR4MAPT
SCHEMBL7367359 0.86 LTA4H (0.87) LTA4HEPHX2CYP4F2CYP4A11FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 470 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-220877929-U Filter equipment of preparation 2- (4-benzene methoxy phenyl) ethanol 杭州盛弗泰新材料科技有限公司 2024-05-03 CN claimed
CN-115557836-A Preparation method of carboxylic acid 云南大学 2023-01-03 CN claimed
CN-113200825-A Preparation method of 2- (4-benzyloxy phenyl) ethanol 上海立科化学科技有限公司 2021-08-03 CN claimed
CN-107880085-B Use of [ Rnim][OSO2OR]Method for synthesizing salidroside by Lewis acid ionic liquid system 枣庄学院 2021-04-09 CN claimed
CN-110818560-A Preparation method of 4-benzyloxy phenyl ethyl n-decanoate 怀化金鑫新材料有限公司 2020-02-21 CN claimed
CN-104592321-A Method for catalytic synthesis of salidroside WUHAN SYNCHALLENGE UNIPHARM INC LTD 2015-05-06 CN claimed
CN-104086378-A Preparation method of 2-(4-benzyloxyphenyl) ethanol NANTONG HUAFENG CHEMICAL CO 2014-10-08 CN claimed
CN-102898289-B Method for synthesizing 2-(4-benzylmethoxyphenyl)ethanol medical intermediate Jiangsu defeng pharmaceutical co ltd 2014-09-03 CN claimed
CN-102898289-A Method for synthesizing 2-(4-benzylmethoxyphenyl)ethanol medical intermediate Jiangsu defeng pharmaceutical co ltd 2013-01-30 CN claimed
CN-101580460-B Synthetic method of 3, 4-dihydroxy phenethyl alcohol TAIZHOU ZHIQING CHEMICAL CO LTD 2012-05-23 CN claimed
WO-2010029566-A2 PROCESS FOR PREPARATION OF PHENOXYPROPANOL AMINES INDOCO REMEDIES LIMITED (IN) 2010-03-18 WO claimed
EP-0538332-A1 POLYCYCLIC GUANINE DERIVATIVES. SCHERING CORP (US) 1993-04-28 EP claimed
JP-1063539-A None JP disclosed
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2026-03-05 US disclosed
EP-3954745-B1 REVERSIBLY THERMOCHROMIC AQUEOUS INK COMPOSITION FOR WRITING UTENSILS, AND REFILL AND WATER-BASED BALLPOINT PEN EACH INTERNALLY CONTAINING SAME KK PILOT CORPORATION ALSO TRADING AS PILOT CORPORATION (JP) 2026-01-07 EP disclosed
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 US disclosed
US-4342783-A TOPICAL SYNTHELABO (FR) 1982-08-03 US disclosed
US-4311708-A ADRENERGIC BLOCKING AGENTS SYNTHELABO (FR) 1982-01-19 US disclosed
US-4252984-A 1-/P-/2-/CYCLOPROPYLMETHOXY/ETHYL/PHENOXY/-3-ISOPROPYLAMINO-2 -PROPANOL SYNTHELABO (FR) 1981-02-24 US disclosed
US-4185115-A Antilipidemic para-[aryl(alkyl or alkenyl)amino]-benzoic acid derivatives AMERICAN CYANAMID COMPANY (US) 1980-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT TYR, SCO2, HBB LTA4H 1562/4885EPHX2 2279/4885CYP4F2 639/4885
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS BCL2, BCL2A1, BAX LTA4H 3870/4885EPHX2 2929/4885CYP4F2 3152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.